Shares of Lyra Therapeutics, Inc. (LYRA) rose 19% on Monday after the company stated that it intends to proceed with an ...

The first head-to-head randomized clinical trial to compare biologics in severe chronic rhinosinusitis with nasal polyps ...

CLEVELAND, Ohio — The Guardians placed DH David Fry on the 10-day injured list today and have recalled OF Jonathan Rodriguez from Triple-A Columbus. Fry, according to the Guardians, sustained multiple ...

Three-year-old Clive has permanent brain damage caused by a rare complication of influenza B. His mother is urging other South Australian parents to vaccinate their children. A South Australian mother ...

A Nevada-based biopharmaceutical company Corstasis Therapeutics has received approval from the US Food and Drug Administration for the bumetanide nasal spray, which could be useful in the treatment of ...

The Minns Labor Government will provide a new free intranasal influenza vaccine for children aged two years to under five years, with the program set to begin next year ahead of the influenza season.

Edema and fluid overload remain the leading causes of hospitalization and readmission for patients with CHF, cirrhosis, and chronic kidney disease. An estimated 6.7 million Americans live with heart ...

The US Food and Drug Administration (FDA) has approved the first intranasal diuretic for heart, liver and kidney disease patients, aiming to prevent a common and costly issue that results in more than ...

ENBUMYST™ is the first and only intranasal loop diuretic approved in the U.S. offering a self-administered alternative between oral and intravenous diuretics. Edema and fluid overload remain the ...